United States

Avanir Pharmaceuticals Inc (AVN)

Track

Ticker: AVN
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 16 May 2014
Value US$1,254,719.35 | Price 345.52 | Shares 21,664 (+16.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2014-05-16 2014-05-16 S Sale OCAMPO CHRISTINE

Vice President, Finance

Officer
21,664 +16.8%
345.52
US$1,254,719 		21,664 +16.8% 345.52 US$1,254,719
2013-12-19 2013-12-17 B Purchase PALEKAR ROHAN

SVP & Chief Commercial Officer

Officer
17,429 -16.8%
344.09
US$1,634,897 		17,429 -16.8% 344.09 US$1,634,897
2013-11-05 2013-11-04 B Purchase PALEKAR ROHAN

SVP & Chief Commercial Officer

Officer
65,349 +44.3%
323.17
US$2,280,016 		65,349 +44.3% 323.17 US$2,280,016
2012-05-14 2012-05-10 B Purchase Siffert Joao MD

SVP, R&D

Officer
2,700 +9.2%
2.96
US$7,992 		2,700 +9.2% 2.96 US$7,992
2012-03-07 2012-03-06 B Purchase MATHEWS CHARLES Non-Executive Director
5,000 +inf%
2.69
US$13,473 		5,000 +inf% 2.69 US$13,473
2012-03-07 2012-03-06 B Purchase OCAMPO CHRISTINE

Vice President, Finance

Officer
3,000 +inf%
2.60
US$7,795 		3,000 +inf% 2.60 US$7,795
2010-11-10 2010-11-09 S Sale Clarus Lifesciences I, L.P. Large shareholder
1,200,000 -15.2%
4.81
US$5,773,920 		1,200,000 -15.2% 4.81 US$5,773,920
2010-11-10 2010-11-08 S Sale Clarus Lifesciences I, L.P. Large shareholder
44,626 -0.6%
5.10
US$227,593 		44,626 -0.6% 5.10 US$227,593
2010-11-05 2010-11-05 S Sale Clarus Lifesciences I, L.P. Large shareholder
332,572 -4.0%
4.80
US$1,597,377 		332,572 -4.0% 4.80 US$1,597,377
2010-11-05 2010-11-03 S Sale Clarus Lifesciences I, L.P. Large shareholder
1,400,106 -14.5%
4.52
US$6,332,539 		1,400,106 -14.5% 4.52 US$6,332,539
2010-11-02 2010-11-02 S Sale Clarus Lifesciences I, L.P. Large shareholder
1,290,871 -11.8%
4.49
US$5,800,400 		1,290,871 -11.8% 4.49 US$5,800,400
2010-11-02 2010-11-01 S Sale Clarus Lifesciences I, L.P. Large shareholder
2,478,142 -18.5%
5.36
US$13,273,424 		2,478,142 -18.5% 5.36 US$13,273,424
2010-11-02 2010-10-29 S Sale Clarus Lifesciences I, L.P. Large shareholder
1,424,947 -9.6%
5.06
US$7,215,647 		1,424,947 -9.6% 5.06 US$7,215,647
2010-10-12 2010-10-11 S Sale Clarus Lifesciences I, L.P. Large shareholder
311,000 -2.1%
3.52
US$1,093,445 		311,000 -2.1% 3.52 US$1,093,445
2010-10-12 2010-10-08 S Sale Clarus Lifesciences I, L.P. Large shareholder
240,838 -1.6%
3.47
US$836,792 		240,838 -1.6% 3.47 US$836,792
2010-07-15 2010-07-13 S Sale Clarus Lifesciences I, L.P. Large shareholder
165,000 -1.1%
3.53
US$583,143 		165,000 -1.1% 3.53 US$583,143
2009-10-13 2009-10-13 S Sale Moorin Jay Large shareholder
547,135 -7.1%
2.23
US$1,220,111 		547,135 -7.1% 2.23 US$1,220,111
2009-10-13 2009-10-12 S Sale Moorin Jay Large shareholder
427,145 -5.3%
2.12
US$905,547 		427,145 -5.3% 2.12 US$905,547
2009-10-13 2009-10-09 S Sale Moorin Jay Large shareholder
804,712 -9.0%
2.46
US$1,979,592 		804,712 -9.0% 2.46 US$1,979,592
2009-08-13 2009-08-11 S Sale Vivo Ventures Fund VI, L.P. Large shareholder
232,450 -2.8%
3.37
US$783,938 		232,450 -2.8% 3.37 US$783,938
2009-08-13 2009-08-11 S Sale Moorin Jay Large shareholder
894,120 -9.1%
3.58
US$3,200,950 		894,120 -9.1% 3.58 US$3,200,950
2009-08-13 2009-08-11 S Sale Vivo Ventures Fund VI, L.P. Large shareholder
49,800 -0.6%
4.05
US$201,690 		49,800 -0.6% 4.05 US$201,690
2009-08-03 2009-07-31 S Sale Vivo Ventures Fund VI, L.P. Large shareholder
1,400 -0.0%
2.20
US$3,080 		1,400 -0.0% 2.20 US$3,080
2009-08-03 2009-07-30 S Sale Vivo Ventures Fund VI, L.P. Large shareholder
142,366 -1.7%
2.29
US$326,445 		142,366 -1.7% 2.29 US$326,445
2009-08-03 2009-07-29 S Sale Vivo Ventures Fund VI, L.P. Large shareholder
145,500 -1.7%
2.28
US$331,245 		145,500 -1.7% 2.28 US$331,245
2009-08-03 2009-07-28 S Sale Vivo Ventures Fund VI, L.P. Large shareholder
122,100 -1.4%
2.42
US$295,714 		122,100 -1.4% 2.42 US$295,714
2008-10-24 2008-10-22 B Purchase Moorin Jay Large shareholder
10,600 +0.1%
0.48
US$5,088 		10,600 +0.1% 0.48 US$5,088
2008-10-15 2008-10-15 B Purchase Moorin Jay Large shareholder
6,465 +0.1%
0.49
US$3,168 		6,465 +0.1% 0.49 US$3,168
2008-10-15 2008-10-14 B Purchase Moorin Jay Large shareholder
32,300 +0.3%
0.50
US$16,150 		32,300 +0.3% 0.50 US$16,150
2008-10-15 2008-10-10 B Purchase Moorin Jay Large shareholder
73,551 +0.8%
0.45
US$33,098 		73,551 +0.8% 0.45 US$33,098
2008-10-10 2008-10-09 B Purchase Moorin Jay Large shareholder
41,385 +0.4%
0.48
US$19,865 		41,385 +0.4% 0.48 US$19,865
2008-10-10 2008-10-08 B Purchase Moorin Jay Large shareholder
114,384 +1.2%
0.50
US$57,192 		114,384 +1.2% 0.50 US$57,192
2008-10-10 2008-10-07 B Purchase Moorin Jay Large shareholder
21,318 +0.2%
0.48
US$10,233 		21,318 +0.2% 0.48 US$10,233
2008-09-17 2008-09-17 B Purchase Moorin Jay Large shareholder
413,217 +4.5%
0.80
US$330,574 		413,217 +4.5% 0.80 US$330,574
2008-09-17 2008-09-16 B Purchase Moorin Jay Large shareholder
17,387 +0.2%
0.76
US$13,214 		17,387 +0.2% 0.76 US$13,214
2008-09-17 2008-09-15 B Purchase Moorin Jay Large shareholder
244,449 +2.8%
0.85
US$207,782 		244,449 +2.8% 0.85 US$207,782
2008-09-10 2008-09-10 B Purchase Moorin Jay Large shareholder
48,103 +0.5%
0.91
US$43,774 		48,103 +0.5% 0.91 US$43,774
2008-09-10 2008-09-09 B Purchase Moorin Jay Large shareholder
146,400 +1.7%
0.92
US$134,688 		146,400 +1.7% 0.92 US$134,688
2008-09-10 2008-09-08 B Purchase Moorin Jay Large shareholder
125,000 +1.5%
0.95
US$118,750 		125,000 +1.5% 0.95 US$118,750
2008-09-04 2008-09-04 B Purchase Moorin Jay Large shareholder
52,113 +0.6%
0.95
US$49,507 		52,113 +0.6% 0.95 US$49,507
2008-09-04 2008-09-03 B Purchase Moorin Jay Large shareholder
6,864 +0.1%
0.93
US$6,384 		6,864 +0.1% 0.93 US$6,384
2008-09-04 2008-09-02 B Purchase Moorin Jay Large shareholder
323,550 +4.0%
0.93
US$300,902 		323,550 +4.0% 0.93 US$300,902
2008-08-29 2008-08-27 B Purchase Moorin Jay Large shareholder
89,447 +1.1%
0.95
US$84,975 		89,447 +1.1% 0.95 US$84,975
2008-08-18 2008-08-15 B Purchase Moorin Jay Large shareholder
114,032 +1.4%
0.95
US$108,330 		114,032 +1.4% 0.95 US$108,330
2008-08-18 2008-08-14 B Purchase Moorin Jay Large shareholder
6,051 +0.1%
0.90
US$5,446 		6,051 +0.1% 0.90 US$5,446
2008-08-08 2008-08-07 B Purchase Moorin Jay Large shareholder
91,380 +1.2%
0.98
US$89,552 		91,380 +1.2% 0.98 US$89,552
2008-08-08 2008-08-06 B Purchase Moorin Jay Large shareholder
400 +0.0%
0.90
US$360 		400 +0.0% 0.90 US$360
2006-06-07 2006-05-31 S Sale SILVERSTEIN JONATHAN Non-Executive Director
629,121 -26.9%
9.79
US$6,159,095 		629,121 -26.9% 9.79 US$6,159,095
2006-06-02 2006-05-31 B Purchase Podlesak Dennis Non-Executive Director
200 +2.8%
9.91
US$1,982 		200 +2.8% 9.91 US$1,982
2006-06-02 2006-05-31 S Sale ORBIMED ADVISORS LLC Non-Executive Director
629,121 -26.9%
9.79
US$6,159,095 		629,121 -26.9% 9.79 US$6,159,095
2006-06-02 2006-05-31 B Purchase Podlesak Dennis Non-Executive Director
800 +12.4%
9.90
US$7,920 		800 +12.4% 9.90 US$7,920
2006-05-26 2006-05-26 B Purchase Kaye Randall

VP of Medical Affairs

Officer
250 +inf%
9.90
US$2,475 		250 +inf% 9.90 US$2,475
2006-05-26 2006-05-26 B Purchase Kaye Randall

VP of Medical Affairs

Officer
200 +400.0%
9.90
US$1,980 		200 +400.0% 9.90 US$1,980
2006-05-26 2006-05-26 B Purchase Kaye Randall

VP of Medical Affairs

Officer
50 +inf%
9.89
US$494 		50 +inf% 9.89 US$494
2006-05-26 2006-05-26 B Purchase HANSON GREGORY P

Vice President, CAO

Officer
100 +2.0%
9.68
US$968 		100 +2.0% 9.68 US$968
2006-05-26 2006-05-26 B Purchase HANSON GREGORY P

Vice President, CAO

Officer
100 +2.0%
9.67
US$967 		100 +2.0% 9.67 US$967
2006-05-26 2006-05-26 B Purchase HANSON GREGORY P

Vice President, CAO

Officer
300 +6.4%
9.69
US$2,907 		300 +6.4% 9.69 US$2,907
2006-05-26 2006-05-26 B Purchase Kaye Randall

VP of Medical Affairs

Officer
2,000 +inf%
10.14
US$20,280 		2,000 +inf% 10.14 US$20,280
2006-05-26 2006-05-26 B Purchase HANSON GREGORY P

Vice President, CAO

Officer
600 +14.8%
9.65
US$5,790 		600 +14.8% 9.65 US$5,790
2006-05-25 2006-05-25 B Purchase BRANDT ERIC

President, CEO & Director

Executive Director
89 +0.0%
8.96
US$797 		89 +0.0% 8.96 US$797
2006-05-25 2006-05-25 B Purchase BRANDT ERIC

President, CEO & Director

Executive Director
2,911 +1.1%
8.97
US$26,112 		2,911 +1.1% 8.97 US$26,112
2006-05-25 2006-05-25 B Purchase BRANDT ERIC

President, CEO & Director

Executive Director
1,700 +0.7%
8.99
US$15,283 		1,700 +0.7% 8.99 US$15,283
2006-05-25 2006-05-25 B Purchase PUNTORIERO MICHAEL J

Senior VP, Finance, CFO

Officer
2,500 +44.4%
9.00
US$22,500 		2,500 +44.4% 9.00 US$22,500
2006-05-25 2006-05-25 B Purchase Katkin Keith

Sr. V.P. of Sales & Marketing

Officer
1,700 +212.5%
9.00
US$15,300 		1,700 +212.5% 9.00 US$15,300
2006-05-25 2006-05-25 B Purchase BRANDT ERIC

President, CEO & Director

Executive Director
6,300 +2.5%
9.00
US$56,700 		6,300 +2.5% 9.00 US$56,700
2006-05-25 2006-05-25 B Purchase EMANUELE ROBERT MARTIN

V P, Business Development

Officer
1,000 +inf%
8.99
US$8,990 		1,000 +inf% 8.99 US$8,990
2006-05-25 2006-05-25 B Purchase PUNTORIERO MICHAEL J

Senior VP, Finance, CFO

Officer
5,000 +800.0%
9.05
US$45,250 		5,000 +800.0% 9.05 US$45,250
2006-05-25 2006-05-25 B Purchase Katkin Keith

Sr. V.P. of Sales & Marketing

Officer
800 +inf%
8.98
US$7,184 		800 +inf% 8.98 US$7,184
2006-02-22 2006-02-17 S Sale SIRCAR JAGADISH C

VP of Drug Discovery

Officer
3,600 -22.2%
16.82
US$60,552 		3,600 -22.2% 16.82 US$60,552
2006-02-15 2006-02-14 B Purchase Mazzo David J Non-Executive Director
1,000 +15.5%
15.59
US$15,590 		1,000 +15.5% 15.59 US$15,590
2005-10-24 2005-10-20 B Purchase SILVERSTEIN JONATHAN Non-Executive Director
566,038 +6.5%
2.65
US$1,500,001 		566,038 +6.5% 2.65 US$1,500,001
2005-04-12 2005-04-08 B Purchase SILVERSTEIN JONATHAN Non-Executive Director
900,000 +11.4%
2.20
US$1,980,000 		900,000 +11.4% 2.20 US$1,980,000
2005-01-03 2005-01-03 PlS Planned sale HANSEN JOHN DAVID

V.P. of Corporate Development

Officer
10,200 -40.5%
3.40
US$34,680 		10,200 -40.5% 3.40 US$34,680
2005-01-03 2005-01-03 PlS Planned sale HANSEN JOHN DAVID

V.P. of Corporate Development

Officer
4,800 -16.0%
3.39
US$16,254 		4,800 -16.0% 3.39 US$16,254
2005-01-03 2005-01-03 PlS Planned sale HANSEN JOHN DAVID

V.P. of Corporate Development

Officer
600 -3.8%
3.42
US$2,052 		600 -3.8% 3.42 US$2,052
Explore more

More insider trading research around Avanir Pharmaceuticals Inc

More insider trades in United States
Insider trading in North America